anonymous
Guest
anonymous
Guest
Augh Puke Charles Kl*g they can have him.
Agree! I never saw the appeal. Just plain weird.
Augh Puke Charles Kl*g they can have him.
And rbAgree! I never saw the appeal. Just plain weird.
Thanks Tad, that very inspirational. I feel more grounded already.
Not to mention high up marketing people and that weirdo CK
That guys was arrogant as you could be and had the personality of a wet towel.Dude. He was a caveman. Talked down to everyone in the field and was about as organized as a tornado. But because he was SR’s guy…
You shut up and be grateful you illiterate punk.Amazing that your still selling this crap! Just shut up and be great full.
He does have a point. Novartis is riding xiidra into the sunset hoping one of their pipline drugs scheduled for 2026 or 2027 actually gets through phase 3. They spent a lot of money on gyroscope. We will see if it ever comes to fruition.You shut up and be grateful you illiterate punk.
He does have a point. Novartis is riding xiidra into the sunset hoping one of their pipline drugs scheduled for 2026 or 2027 actually gets through phase 3. They spent a lot of money on gyroscope. We will see if it ever comes to fruition.
xidra sold to bausch
But remember it was just rumors and speculation everyone!!!!
Hopefully we don’t have too much longer…
Anybody remember this from that Reuters article back in November?
“Any sale of the ophthalmology and respiratory businesses is likely to begin in 2023, after the process for Sandoz is completed, the Bloomberg report said.”
The Sandoz spin-off will be complete “in the second half of 2023.”
I can’t believe I literally wrote this yesterday! Lmao
You didn’t write itI can’t believe I literally wrote this yesterday! Lmao
The plot thickens!You didn’t write it